Raul Felipe Abella

Raul Felipe Abella

Auto-generated profile, based on publicly available information

Raul Felipe Abella

Pediatric Cardiovascular Surgery Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
MBMelinda Barkhuizen
Melinda Barkhuizen
RARaul Abella
Raul Abella
JVJ. S. Hans Vles
J. S. Hans Vles
LZLuc J.I. Zimmermann
Luc J.I. Zimmermann
DGDiego Gazzolo
Diego Gazzolo
DGDanilo AW Gavilanes
Danilo AW Gavilanes
Congenital heart defects (CHD) is one of the most common types of birth defects. Thanks to advances in surgical techniques and intensive care, the majority of children with severe forms of CHD survive into adulthood. However, this increase in survival comes with a cost. CHD survivors have neurological functioning at the bottom of the normal range. A large spectrum of central nervous system dysmaturation leads to the deficits seen in critical CHD. The heart develops early during gestation, and CHD has a profound effect on fetal brain development for the remainder of gestation. Term infants with critical CHD are born with an immature brain, which is highly susceptible to hypoxic-ischemic injuries. Perioperative blood flow disturbances due to the CHD and the use of cardiopulmonary bypass or circulatory arrest during surgery cause additional neurological injuries. Innate patient factors, such as genetic syndromes and preterm birth, and postoperative complications play a larger role in neurological injury than perioperative factors. Strategies to reduce the disability burden in critical CHD survivors are urgently needed.

22 August 2012 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
RARaul Abella
Raul Abella
ASAngela Satriano
Angela Satriano
AFAlessandro Frigiola
Alessandro Frigiola
AVAlessandro Varrica
Alessandro Varrica
DGDanilo AW Gavilanes
Danilo AW Gavilanes
DGDiego Gazzolo
Diego Gazzolo
Background: Low cardiac output syndrome (LCOS) remains a major perioperative complications in infants subjected to open-heart surgery with cardiopulmonary bypass (CPB). The present study investigated whether perioperative blood assessment of a potent vasoactive peptide namely adrenomedullin (AM) can predict the risk of LCOS. Methods: We measured AM levels in 48 patients (LCOS: n = 9; controls: n = 39) undergone to open-heart surgery with CPB at five predetermined time points before, during and after the surgery. Clinical, laboratory and perioperative data were analyzed by a multiple logistic regression model. Results: AM significantly decreased (p < 0.01) during and after the surgical procedure exhibiting a dip at the end of the CPB. Multivariable analysis demonstrated significant correlations among LCOS, AM measured at the end of CPB (p < 0.001), and cooling duration (p < 0.05). AM at 27 pg/L cutoff achieved a sensitivity of 100% and a specificity of 64.1%, while cooling at 11-min cutoff combined a sensitivity of 55.6% and a specificity of 92.3% for LCOS prediction. Conclusions: This study suggests that AM can constitute, alone or combined with standard parameters, a promising predictor of LCOS in infants subjected to open-heart surgery with CPB.

1 February 2023 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
JMJuan José Menéndez
Juan José Menéndez
ASAmelia Caridad Sánchez-Galindo
Amelia Caridad Sánchez-Galindo
JBJoan Balcells
Joan Balcells
MTMaría Ángeles Tejero-Hernández
María Ángeles Tejero-Hernández
ÁFÁngela Ferrer-Barba
Ángela Ferrer-Barba
LGLuis Garcia-Gueretaa
Luis Garcia-Gueretaa
To describe the use of ventricular assist devices (VAD) in children in Spain and to identify variables related to survival. This is an observational cohort study of all children younger than 18 years of age who underwent an initial implantation of a VAD at any of the six paediatric heart transplant centers from May 2006 to December 2020. Subjects were identified retrospectively from each hospital's database. Paracorporeal VADs were implanted in 118 children (pulsatile [63%], continuous [30.5%] or both types [5.9%]). Small children (< 0.7 m2 of body surface area) comprised the majority of this cohort (63.3%). Overall, 67% survived to VAD explantation, and 64.9% survived to hospital discharge. Non-central nervous system haemorrhage (39%) and stroke (38.1%) were the most common complications. Body weight 34 μmol/L and bridge to decision strategy, were associated with a higher mortality at hospital discharge and in the long-term. Interagency registry for mechanically assisted circulatory support (INTERMACS) status 1 and cardiac arrest prior to VAD implantation were related to long-term mortality, whereas pre-implantation renal replacement therapy and extracorporeal membrane oxygenation were not related to mortality. In Spain, 67% of the VAD-supported children have been bridged to heart transplantation or to recovery. Body weight lower than 5 Kg, congenital heart disease diagnosis, cholestatic liver dysfunction, bridge to decision as VAD strategy, INTERMACS-1 status and cardiac arrest were pre-implantation variables related to mortality, whereas pre-implantation renal replacement therapy and extracorporeal membrane oxygenation were not.

1 November 2019 in The Annals of Thoracic Surgery
Verified
Journal Article
Open access
JSJose Manuel Siurana
Jose Manuel Siurana
JFJoaquin Fernández
Joaquin Fernández
ANAlexandra Navarro
Alexandra Navarro
GAGeorges Akel
Georges Akel
RARaul Felipe Abella
Raul Felipe Abella
DADimpna Calila Albert-Brotons
Dimpna Calila Albert-Brotons
This case report describes a primary cardiac tumor, classified as venous malformation, diagnosed in an asymptomatic child. The tumor was located in the left atrium near the mitral valve without affecting the mitral valve's functioning. Complete resection of the lesion was performed because of the risk of systemic embolism. The lesion consisted of fibrous tissue with multiple venous vascular channels. The patient did not have similar lesions in other locations. Vascular primary cardiac tumors are extremely rare. Hemangiomas and lymphangiomas have been described previously, but to our knowledge, this is the first primary cardiac tumor identified as a venous malformation.

17 September 2021 in Indian Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
JFJoaquín Fernandez-Doblas
Joaquín Fernandez-Doblas
APAntonio Pamies-Catalan
Antonio Pamies-Catalan
PDPaola Dolader
Paola Dolader
QFQueralt Ferrer
Queralt Ferrer
RARaul F. Abella
Raul F. Abella